### Single-Cell Analysis Report
Dataset: bone_marrow.h5ad

# 1) What cell types did you identify? (one line per annotated cluster)

Decidual cells

Naïve T cells

γδ (gamma–delta) T cells

Nuocytes / ILC2-like cells

Alveolar macrophages

Parietal cells (gastric)

Trophoblast progenitor cells

Monocytes

Pancreatic progenitor cells

Delta cells (pancreatic, somatostatin-secreting)

Loop of Henle cells (renal)

Luteal cells (ovarian)

Pluripotent stem cells / rare progenitors

# 2) Biological role of each annotated label (tight 1–2 sentences each)

Decidual cells: specialized uterine stromal cells that support implantation and regulate local immune tolerance during pregnancy.

Naïve T cells: antigen-inexperienced adaptive lymphocytes circulating or resident that can be activated to expand and differentiate upon antigen encounter.

Gamma–delta (γδ) T cells: unconventional T cells with innate-like functions — rapid cytokine production and tissue surveillance, often important in barrier tissues and early infection responses.

Nuocytes / ILC2-like cells: type-2 innate lymphoid cells (ILC2) involved in type-2 immunity, tissue repair and production of IL-5/IL-13, active in mucosal and barrier tissues.

Alveolar macrophages: lung-resident macrophages responsible for clearing debris/pathogens, orchestrating pulmonary immune responses and tissue homeostasis.

Parietal cells: gastric epithelial cells that secrete hydrochloric acid and intrinsic factor — epithelial, not immune.

Trophoblast progenitor cells: placental progenitors giving rise to trophoblast lineages; involved in implantation and placenta formation.

Monocytes: circulating mononuclear phagocytes; phagocytose pathogens, produce cytokines, and can differentiate into macrophages or dendritic cells.

Pancreatic progenitor cells: endocrine/exocrine precursors in pancreas development — not part of typical immune compartment.

Delta cells (pancreas): somatostatin-secreting islet cells — endocrine function.

Loop of Henle cells: renal tubular epithelial cells of the nephron — transport and concentration of urine.

Luteal cells: ovarian corpus luteum cells — steroidogenic/endocrine role in reproductive cycle.

Pluripotent stem cells: rare cells with broad differentiation capacity; presence typically indicates stem-like contamination or experimental introduction.

# 3) Is the tissue source really bone marrow? — rigorous reasoning

Short answer: No — this is not a bona fide whole bone-marrow sample. The composition and the presence of many tissue-specific epithelial and reproductive/placental cell types contradict marrow biology.

Evidence (explicit, numbered)

Tissue-specific epithelial cells dominate. Decidual cells (24.1%), parietal gastric cells (7.3%), loop-of-Henle renal cells (1.8%), pancreatic progenitors and delta cells (≈7.4% combined), luteal cells (1.4%), and trophoblast progenitors (5.5%) are epithelial/endocrine/placental lineages — these do not belong in a normal bone marrow aspirate.

Absence of canonical marrow-myeloid dominance. True bone marrow typically contains abundant erythroid precursors, granulocytes (neutrophils and precursors), monocytes/myelopoiesis, and measurable HSC/progenitor compartments. Here:

Erythroid lineage is essentially absent (no erythroid cluster reported).

Neutrophils/granulocyte clusters are absent.

Pluripotent/HSC-like population is vanishingly small (0.09%) — atypical for marrow.

High lymphoid/ILC/tissue-resident signals (naïve T 18.7%, γδ T 10.5%, nuocytes 9.5%, alveolar macrophages 8.7%) more closely match multi-tissue or organ-specific immune cell mixes rather than marrow composition.

Co-occurrence of placenta/decidua markers (decidual + trophoblast progenitors) implies either placental/uterine tissue, a multi-sample reference, or misannotation due to marker overlap.

Logical conclusion with explicit caveats

Conclusion: The sample is not whole bone marrow; it is either (A) a mixture of cells from multiple tissues (placenta/uterus/lung/pancreas/ kidney/ovary + immune cells), or (B) annotations are partially mis-assigned because marker-to-cell-type mapping pulled tissue-specific labels from a reference (e.g., Panglao or other atlases) that don’t reflect your actual sample.

Flaws in a bone-marrow claim: claiming “bone marrow” would ignore the numerous tissue-specific epithelial clusters and the absence of marrow hallmark populations. The only way to salvage a marrow claim would be to show metadata indicating a marrow aspirate and to demonstrate that epithelial/placental signatures are contamination or mapping artefacts — both of which require extra evidence (metadata, raw counts, mapping tables). Without that, a marrow assignment would be hand-wavy.

# 4) Healthy vs infected? — defended using requested axes

Short answer: Cannot confidently call “infected” from this dataset alone. There are immune populations (γδ T, nuocytes, alveolar macrophages, monocytes, T cells) compatible with local immune activity in multiple tissues, but the presence of many tissue-specific non-immune cell types and the lack of neutrophil/granulocyte signal make a systemic infection call unwarranted.

Detailed evidence by requested features

Neutrophils: Absent. Acute bacterial infections usually show neutrophil/granulocyte expansion, especially in marrow or peripheral blood. The absence argues against diagnosing acute bacterial infection from these proportions.

Monocytes: ~5.06% — a modest monocyte fraction. Monocytosis (large increases) can indicate inflammation, but 5% is within many steady-state tissue samples (and may reflect sampling of tissue macrophage lineages). Alone this does not indicate systemic infection.

NK cell activation states (proxy here): You have nuocytes (ILC2) at ~9.5% and substantial T cell subpopulations (~29% combined naive + γδ). Classic NK cluster label is not present (so we can't assess NK activation directly). If NKs were present and expressing cytotoxic genes/ISGs, that would favor viral activation — but here we lack a designated NK cluster to evaluate.

Lymphocyte depletion/expansion: There is substantial lymphocyte/ILC presence (naïve T + γδ T + nuocytes), which implies active or tissue-resident adaptive/innate immunity in the tissues represented. That could reflect local tissue immune homeostasis or localized inflammation (e.g., lung inflammation if alveolar macrophages + γδ T present), not necessarily systemic infection.

Overall interpretation

Most supported interpretation: This dataset represents multi-tissue sampling or a heterogeneous tissue with local immune populations (uterine/placental cells + lung macrophages + pancreatic/renal/ovarian epithelial cells). The immune composition suggests local tissue immune surveillance or prior/ongoing local inflammation, not a clear systemic infection.

What would change the call to “infected”: evidence of activated innate antiviral signatures (ISG upregulation across immune clusters), strong expansion of NK cytotoxic markers, markedly elevated monocyte inflammatory markers (IL1B, TNF), or detection of pathogen transcripts. Absent those, label the dataset as inconclusive for infection.

Recommendations / next tests (concrete, actionable — run these to move from hypothesis to evidence)

Verify annotations vs marker genes — produce dotplots/violin plots for canonical markers for each reported cell type to confirm labels (examples below). If many "decidual" or "parietal" labels are driven by a few ambiguous markers, re-annotate using consensus markers.

Immune markers: CD3D, CD8A, CD4, TRDC (γδ T), GATA3/IL7R (ILC2), NKG7, GZMB (cytotoxic), LYZ/CD14 (monocytes), MARCO, MRC1 (alveolar macrophages).

Epithelial markers: HLA-G, CGB (trophoblast), ATP4A/ATP4B (parietal cells), UMOD/SLC12A1 (Loop of Henle), pancreatic markers INS, SST, PDX1.

Check sample metadata — did this come from a multi-sample atlas, a reference mapping, or a single biopsy? Metadata will resolve tissue-origin questions quickly.

ISG / interferon score — compute ISG gene set score (IFITs, MX1, ISG15, OAS) per cell and inspect cluster-level distributions; statistically test cluster means (permutation or t-test). Elevated ISG in immune clusters supports viral activation.

Search for pathogen transcripts (if raw FASTQ/unmapped reads are available) or at least for viral genome–aligned reads. Presence would be direct evidence.

Permutation / bootstrap tests for proportions — compare your cluster proportions to expected reference distributions for each claimed tissue (if you have a plausible reference set). Report p-values and CIs.

If annotations appear noisy, re-run annotation using conservative marker sets or transfer-learning (e.g., CellTypist / scANVI) and report confusion matrix.

Compact summary:

I annotated 13 clusters dominated by decidual/epithelial tissues (decidua 24%), naive and γδ T cells (~29% combined), nuocytes (~9.5%), alveolar macrophages (~8.7%), and several organ-specific epithelial progenitors. This composition is incompatible with an unselected bone-marrow aspirate (which should be myeloid/erythroid-progenitor–rich). Instead the dataset appears to represent multiple tissue types or mis-annotations from a reference mapping. Immune clusters show signals consistent with local tissue immunity rather than a clear systemic infection: neutrophils are absent (argues against bacterial sepsis), monocytes are modest (~5%), and definitive NK activation cannot be assessed because a canonical NK cluster is not annotated. To move from hypothesis to evidence, confirm annotations with canonical marker plots, check metadata for sample origin, compute ISG scores, and perform permutation/bootstrap tests for cluster proportion deviations.
